IP Library Assignment 044405/0435
Patent Assignment
Reel/Frame 044405/0435

Assignment of Assignor's Interest

Recorded: 2017-12-15 Pages: 5
Assignor
KOZARSKY, KAREN, PH.D
Executed: 2017-09-14
Assignee
REGENXBIO INC.
9600 BLACKWELL ROAD, SUITE 210, ROCKVILLE, MARYLAND, 20850
Covered Property (1)
Methods to Treat Mucopolysaccharidosis Type Ii or Deficiency in Iduronate-2-Sulfatase Using a Recombinant Adeno-Associated Virus (Aav) Vector Encoding Iduronate-2-Sulfatase
Application: 15/717,358 →
Publication: US 2018/0099030
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License Nov 2, 2017
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044351/0408 →
Assignment of Assignor's Interest Dec 15, 2017
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.; LOW, WALTER; FAIRBANKS, CAROLYN
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 044405/0603 →
Assignment of Assignor's Interest Jul 7, 2025
From: REGENXBIO INC.
To: REGENXBIO RS LLC
Reel/Frame 071840/0471 →